Advancing the Science of Neonatal Sepsis Prevention
Antibodies passed from mothers to their babies during pregnancy help protect newborns against infection. Research led by Cincinnati Children’s is exploring why that protection may be weaker in some infants—and whether strengthening it could help prevent serious illness.
The study found that newborns with Escherichia coli sepsis had lower levels of maternally transferred antibodies directed against the bacteria. Those antibodies were also less effective at helping the immune system target the bacteria.
For neonatologists, maternal-fetal medicine specialists and pediatric infectious diseases physicians, the findings offer insight into how maternal immunity may influence newborn infection risk. They also point toward potential ways to identify infants that are the most vulnerable to infection.
Understanding Differences in Newborn Protection
Published March 11, 2026, in Nature, the study examined dried blood spot specimens collected one day after birth from 100 babies with E. coli sepsis. Researchers compared them with specimens from infants without infection who were individually matched for sex, gestational age and birth timing.
Infants with sepsis had lower levels of E. coli-specific immunoglobulin G (IgG) and reduced antibody-dependent opsonization, a process that helps the immune system recognize and clear bacteria.
The findings suggest that pathogen-targeted antibodies naturally transferred from mothers protect most babies against infection, whereas babies receiving diminished antibodies are particularly susceptible.
Senior author Sing Sing Way, MD, PhD, of Cincinnati Children’s Division of Infectious Diseases, explained that these protective antibodies are stimulated by common intestinal bacteria in mothers, and transferred to their babies during pregnancy.
Exploring Ways to Strengthen Maternal Immunity
In complementary preclinical studies, researchers tested whether maternal intestinal colonization with probiotic non-pathogenic E. coli before pregnancy could stimulate protective antibodies. Babies born to E. coli colonized mothers were dramatically less susceptible to infection following maternal colonization.
These results suggest a possible approach to strengthening the protection passed from mothers to babies. Researchers are also exploring how the findings might help identify newborns who are most at-risk for serious infection and need greater protection.
What the Findings Mean for Clinical Care
Screening and prevention remain future goals. The study does not establish an antibody screening test for routine care or show that maternal probiotic use safely prevents neonatal E. coli sepsis in humans. But investigators plan to develop a screening test to identify newborns at highest risk and, eventually, a probiotic safe for mothers that could strengthen the immunity transferred to their babies.
For clinicians, the research offers a clearer picture for why some babies develop infection while most babies do not. Further work will determine whether measuring or strengthening these antibodies can help prevent serious infection.
Discuss the research: Contact Sing Sing Way, MD, PhD, at singsing.way@cchmc.org.
(Published November 2026)



